Parus Finance (Uk) LTD Moderna, Inc. Transaction History
Parus Finance (Uk) LTD
- $345 Million
- Q2 2024
A detailed history of Parus Finance (Uk) LTD transactions in Moderna, Inc. stock. As of the latest transaction made, Parus Finance (Uk) LTD holds 26,328 shares of MRNA stock, worth $1.36 Million. This represents 0.91% of its overall portfolio holdings.
Number of Shares
26,328
Previous 25,884
1.72%
Holding current value
$1.36 Million
Previous $2.76 Million
13.34%
% of portfolio
0.91%
Previous 1.04%
Shares
15 transactions
Others Institutions Holding MRNA
# of Institutions
1,027Shares Held
241MCall Options Held
9.26MPut Options Held
12.1M-
Baillie Gifford & CO42.5MShares$2.2 Billion2.17% of portfolio
-
Vanguard Group Inc Valley Forge, PA39.6MShares$2.05 Billion0.09% of portfolio
-
Black Rock Inc. New York, NY25.6MShares$1.32 Billion0.07% of portfolio
-
State Street Corp Boston, MA15MShares$778 Million0.08% of portfolio
-
Theleme Partners LLP London, X07.23MShares$374 Million42.67% of portfolio
About Moderna, Inc.
- Ticker MRNA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 391,200,000
- Market Cap $20.3B
- Description
- Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...